Optimizing combination chemotherapy for Kaposi's sarcoma.
Yarchoan
R
R
HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1906, USA.
Little
R
R
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D012514:Sarcoma, Kaposi / Q000188:drug therapy*
D016178:Granulocyte-Macrophage Colony-Stimulating Factor